Publications by authors named "Ken Furuya"

Claim this Profile
O
Once-Daily Oral Ozanimod for Japanese Patients With Ulcerative Colitis: Results From the Phase 2/3 J-True North Study.
Hiroshi Nakase, Toshimitsu Fujii, Tadakazu Hisamatsu, Yasuo Suzuki, Mamoru Watanabe, Ken Furuya

Gastro Hep Adv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distribution of Fibrosis-4 index and vibration-controlled transient elastography-derived liver stiffness measurement for patients with metabolic dysfunction-associated steatotic liver disease in health check-up.
Yuji Ogawa, Wataru Tomeno, Yasushi Imamura, Masaru Baba, Takato Ueno, Ken Furuya

Hepatol Res· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Febrile Reactions Associated with High IgG Antibody Titers after the Second and Third BNT162b2 Vaccinations in Japan.
Nobuyasu Wakazono, Katsura Nagai, Arei Mizushima, Yukiko Maeda, Natsuko Taniguchi, Ken Furuya

Jpn J Infect Dis· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Coexistence of Dominant Marine Phytoplankton Sustained by Nutrient Specialization.
Takako Masuda, Keisuke Inomura, Jan Mareš, Taketoshi Kodama, Takuhei Shiozaki, Ken Furuya

Microbiol Spectr· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Heterogeneous nitrogen fixation rates confer energetic advantage and expanded ecological niche of unicellular diazotroph populations.
Takako Masuda, Keisuke Inomura, Naoto Takahata, Takuhei Shiozaki, Yuji Sano, Ken Furuya

Commun Biol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low Baseline CXCL9 Predicts Early Progressive Disease in Unresectable HCC with Atezolizumab Plus Bevacizumab Treatment.
Shunichi Hosoda, Goki Suda, Takuya Sho, Koji Ogawa, Megumi Kimura, Ken Furuya

Liver Cancer· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prophylactic tenofovir alafenamide for hepatitis B virus reactivation and reactivation-related hepatitis.
Goki Suda, Masaru Baba, Yoshiya Yamamoto, Takuya Sho, Koji Ogawa, Ken Furuya

J Med Virol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum Angiopoietin-2 Predicts the Occurrence and Recurrence of Hepatocellular Carcinoma after Direct-Acting Antiviral Therapy for Hepatitis C.
Naoki Kawagishi, Goki Suda, Yoshiya Yamamoto, Masaru Baba, Ken Furuya

Viruses· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
as a Major Consumer of Fixed Nitrogen.
Takako Masuda, Keisuke Inomura, Taketoshi Kodama, Takuhei Shiozaki, Satoshi Kitajima, Ken Furuya

Microbiol Spectr· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Effect on Liver Functional Reserve of Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma in Patients Who Do Not Meet Eligibility Criteria of IMbrave150.
Takuya Sho, Goki Suda, Yoshiya Yamamoto, Ken Furuya, Masaru Baba

Cancers (Basel)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction of hepatocellular carcinoma using age and liver stiffness on transient elastography after hepatitis C virus eradication.
Masato Nakai, Yoshiya Yamamoto, Masaru Baba, Goki Suda, Akinori Kubo, Ken Furuya

Sci Rep· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of liver scintigraphy and the liver-spleen contrast in Gd-EOB-DTPA-enhanced MRI on liver function tests.
Hiroshige Mori, Hanaka Machimura, Amika Iwaya, Masaru Baba, Ken Furuya

Sci Rep· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline serum angiopoietin-2 and VEGF levels predict the deterioration of the liver functional reserve during lenvatinib treatment for hepatocellular carcinoma.
Taku Shigesawa, Goki Suda, Megumi Kimura, Osamu Maehara, Yoshimasa Tokuchi, Ken Furuya

PLoS One· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early response and safety of atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma in patients who do not meet IMbrave150 eligibility criteria.
Takuya Sho, Goki Suda, Koji Ogawa, Megumi Kimura, Akinori Kubo, Ken Furuya

Hepatol Res· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nanomolar phosphate supply and its recycling drive net community production in the subtropical North Pacific.
Fuminori Hashihama, Ichiro Yasuda, Aki Kumabe, Mitsuhide Sato, Hiroshi Sasaoka, Ken Furuya

Nat Commun· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multidrug treatment for COVID-19.
Masashi Ohe, Ken Furuya, Houman Goudarzi

Drug Discov Ther· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tenofovir-disoproxil-fumarate modulates lipid metabolism via hepatic CD36/PPAR-alpha activation in hepatitis B virus infection.
Kazuharu Suzuki, Goki Suda, Yoshiya Yamamoto, Ken Furuya, Masaru Baba

J Gastroenterol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tetracycline plus macrolide: A potential therapeutic regimen for COVID-19?
Masashi Ohe, Ken Furuya, Houman Goudarzi

Biosci Trends· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal and Vertical Variations of Dissolved Labile Phosphoric Monoesters and Diesters in the Subtropical North Pacific.
Tamaha Yamaguchi, Mitsuhide Sato, Fuminori Hashihama, Haruka Kato, Takanori Sugiyama, Ken Furuya

Front Microbiol· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High Productivity of Eicosapentaenoic Acid and Fucoxanthin by a Marine Diatom in a Semi-Continuous Culture.
Saki Tachihana, Norio Nagao, Tomoyo Katayama, Minamo Hirahara, Fatimah Md Yusoff, Ken Furuya

Front Bioeng Biotechnol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioprospecting of indigenous marine microalgae with ammonium tolerance from aquaculture ponds for microalgae cultivation with ammonium-rich wastewaters.
Tomoyo Katayama, Norio Nagao, Nor Azman Kasan, Helena Khatoon, Norazira Abdu Rahman, Ken Furuya

J Biotechnol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenvatinib in patients with unresectable hepatocellular carcinoma who do not meet the REFLECT trial eligibility criteria.
Takuya Sho, Goki Suda, Koji Ogawa, Taku Shigesawa, Kazuharu Suzuki, Ken Furuya

Hepatol Res· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macrolide treatment for COVID-19: Will this be the way forward?
Masashi Ohe, Haruki Shida, Satoshi Jodo, Yoshihiro Kusunoki, Masahide Seki, Ken Furuya

Biosci Trends· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heterogeneous nitrogen fixation rates confer energetic advantage and expanded ecological niche of unicellular diazotroph populations.
Takako Masuda, Keisuke Inomura, Naoto Takahata, Takuhei Shiozaki, Yuji Sano, Ken Furuya

Commun Biol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early response and safety of lenvatinib for patients with advanced hepatocellular carcinoma in a real-world setting.
Takuya Sho, Goki Suda, Koji Ogawa, Megumi Kimura, Tomoe Shimazaki, Ken Furuya

JGH Open· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis